| __timestamp | GSK plc | Wave Life Sciences Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 8246000000 | 2999000 |
| Thursday, January 1, 2015 | 9232000000 | 10393000 |
| Friday, January 1, 2016 | 9366000000 | 15994000 |
| Sunday, January 1, 2017 | 9672000000 | 26975000 |
| Monday, January 1, 2018 | 9915000000 | 39509000 |
| Tuesday, January 1, 2019 | 11402000000 | 48869000 |
| Wednesday, January 1, 2020 | 11456000000 | 42510000 |
| Friday, January 1, 2021 | 10975000000 | 46105000 |
| Saturday, January 1, 2022 | 8372000000 | 50513000 |
| Sunday, January 1, 2023 | 9385000000 | 51292000 |
Unveiling the hidden dimensions of data
In the world of pharmaceuticals and biotechnology, operational efficiency is key. This analysis compares the Selling, General, and Administrative (SG&A) expenses of GSK plc and Wave Life Sciences Ltd. from 2014 to 2023. GSK, a global healthcare giant, consistently reported SG&A expenses in the range of $8.2 billion to $11.5 billion annually. In contrast, Wave Life Sciences, a smaller biotech firm, showed a steady increase from $3 million to over $51 million in the same period.
This comparison underscores the diverse strategies of established and emerging players in the industry, offering insights into their operational priorities.
AbbVie Inc. vs Wave Life Sciences Ltd.: SG&A Expense Trends
Vertex Pharmaceuticals Incorporated vs Wave Life Sciences Ltd.: SG&A Expense Trends
Selling, General, and Administrative Costs: Zoetis Inc. vs Wave Life Sciences Ltd.
GSK plc and Blueprint Medicines Corporation: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: GSK plc vs Sarepta Therapeutics, Inc.
Comparing SG&A Expenses: GSK plc vs Exelixis, Inc. Trends and Insights
GSK plc vs Axsome Therapeutics, Inc.: SG&A Expense Trends
GSK plc or Corcept Therapeutics Incorporated: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for United Therapeutics Corporation and Wave Life Sciences Ltd.
Operational Costs Compared: SG&A Analysis of Grifols, S.A. and Wave Life Sciences Ltd.
Operational Costs Compared: SG&A Analysis of Ligand Pharmaceuticals Incorporated and Wave Life Sciences Ltd.
Cost Management Insights: SG&A Expenses for Iovance Biotherapeutics, Inc. and Wave Life Sciences Ltd.